SEC Form 4: Valliant John sold $77,694 worth of shares (10,300 units at $7.54) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 367,260 units

ByQuantisnow·Wall Street's wire, on your screen.

FUSN· Fusion Pharmaceuticals Inc.

Health Care

Original source

SEC Form 4: Valliant John sold $77,694 worth of shares (10,300 units at $7.54) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 367,260 units | Quantisnow